Search clinical trials for: Coronary scaffold

Total 9889 results

Shenzhen People's Hospital

Unknown

Bioabsorbable Scaffold vs Drug-coated Balloon for Coronary de Novo Lesions in STEMI: Prospective Observational Trial (NeovasvsDCB)

Cardiovascular Diseases

China
Inova Health Care Services

Withdrawn

Thrombogenicity Assessment in Patients Treated With Bioresorbable Vascular Scaffolds

Coronary Artery Disease

United States
University of Ulm

Completed

Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold (CSI-Ulm-BVS)

Coronary Artery Disease | Ischemic Heart Disease | Stable Angina | Acute Myocardial Infarction | Unstable Angina

Germany
University of Ulm

Completed

Coronary and Structural Interventions Ulm - Coronary Chronic Total Occlusions (CSI-Ulm-CTO)

Coronary Artery Disease | Ischemic Heart Disease | Stable Angina

Germany
Hospital Clinic of Barcelona
Spanish Society of Cardiology

Completed

MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction (MAGSTEMI)

Acute Coronary Syndrome | ST Segment Elevation Myocardial Infarction | Stent

Spain
Lifetech Scientific (Shenzhen) Co., Ltd.

Unknown

Feasibility, Efficacy and Safety of IBS ® for Implantaiton in the PDA in Duct-dependent Cyanotic CHD

Patent Ductus Arteriosus | Duct-dependent Cyanotic Congenital Heart Disease

Malaysia
San Luigi Gonzaga Hospital
University Hospital of Ferrara

Active, not recruiting

MAGnesIum Alloy Scaffold for Coronary Artery Disease (MAGIC) (MAGIC)

Myocardial Infarction | Coronary Artery Disease

Italy
Biotronik AG

Unknown

First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II) (BIOSOLVE-II)

Coronary Artery Disease | Coronary Artery Stenosis

Spain, Denmark, Germany, Brazil, Belgium, Netherlands, Singapore, Switzerland
Biotronik AG

Completed

Pre-market Study of the DREAMS 2G Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-III) (BIOSOLVE-III)

Coronary Artery Disease | Coronary Artery Stenosis

Germany, Belgium, Netherlands, Switzerland
Hospital Clinic of Barcelona
AstraZeneca

Completed

TIcaGrEloR and ABSORB Bioresorbable Vascular Scaffold Implantation for Recovery of Vascular Function After Successful Chronic Total Occlusion Recanalization (TIGER-BVS)

Patients Who Are Scheduled to Undergo a PCI (Percutaneous Coronary Intervention) for CTO (Chronic Total Occlusion)

Spain
Abbott Medical Devices

Completed

A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) System in Chinese Population ~ ABSORB CHINA Randomized Controlled Trial (RCT) (ABSORB CHINA)

Coronary Artery Disease | Coronary Disease | Coronary Stenosis | Coronary Artery Stenosis

United States
Shanghai Bio-heart Biological Technology Co., Ltd.
CCRF Inc., Beijing, China

Active, not recruiting

Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study

Coronary Artery Disease | Antineoplastic Agents

China
Abbott Medical Devices

Completed

ABSORB II Randomized Controlled Trial (ABSORB II)

Coronary Artery Disease

Belgium
University of Luebeck
Charite University, Berlin, Germany; Kerckhoff Klinik; University of Schleswig-Holstein...

Terminated

EverolimuS-ElUtinG BioresorbAble VasculaR Scaffolds vErsus EVerolimus-Eluting Stents in Patients With Diabetes Mellitus (SUGAR-EVE)

Coronary Artery Disease | Diabetes Mellitus

Germany
University of Luebeck

Terminated

Bioresorbable Vascular Scaffolds Versus Stents in Patients With Chronic Total Occlusion (SCORE-CTO)

Coronary Artery Disease

Germany
Charite University, Berlin, Germany

Terminated

SOLVE-ACS: Bioresorbable Magnesium-Stents Magmaris in ACS Lesions (SOLVE-ACS)

Acute Coronary Syndrome | NSTEMI - Non-ST Segment Elevation MI | STEMI - ST Elevation Myocardial Infarction

Germany
University Hospital, Toulouse
Boston Scientific Corporation

Completed

Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction (COVER-AMI)

Acute Coronary Syndrome

France
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Amsterdam Investigator-initiateD Absorb Strategy All-comers Trial (AIDA)

Myocardial Infarction | Coronary Artery Disease

Netherlands
Abbott Medical Devices

Completed

To Study the Safety and Clinical Outcomes of the Absorb Bioresorbable Vascular Scaffold (BVS) System in Patients With de Novo Lesions in Previously Untreated Vessels (ABSORB UK)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United Kingdom
International Foundation for Development of Medical...
KCRI

Completed

Feasibility and Outcomes of Complete Coronary Revascularization Using BVS in All-comer Patients With Angina (FEASTRU)

Angina

Russian Federation
University of Jena
KKS Netzwerk

Terminated

Comparison of Paclitaxel-Coated Balloons Against Drug-Eluting Bioresorbable Scaffolds for Elective PCI Using OCT (OCTOPUS-3)

Coronary Artery Disease

Germany
Young-Hak Kim, MD, PhD
Abbott Medical Devices

Terminated

Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus IntraVascular Ultrasound for BiorEsorbable Vascular Scaffold Implantation (ACTIV-BVS)

Coronary Artery Disease

Korea, Republic of
Meril Life Sciences Pvt. Ltd.

Unknown

Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System (MeRes-1Extend)

Coronary Artery Disease

Malaysia, Brazil, Indonesia, Macedonia, The Former Yugoslav Republic of
European Cardiovascular Research Center

Active, not recruiting

ABSORB Bioresorbable Scaffold vs. Xience Metallic Stent for Prevention of Restenosis in Patients at High Risk of Restenosis (Compare Absorb)

Coronary Artery Lesion

Italy, Spain, Belgium, Germany, United Kingdom, France, Czechia, Poland, Netherlands
LMU Klinikum
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

Completed

Vascular Healing After BVS-implantation

Coronary Heart Disease

Germany
Deutsches Herzzentrum Muenchen

Unknown

A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction (ISAR-Absorb MI)

Myocardial Infarction | Cardiovascular Disease | Thrombus | Primary Angioplasty

Germany
Institut d'Investigació Biomèdica de Bellvitge
Fundació La Marató de TV3

Completed

Comparison of the Vasomotor Function and Myocardial Flow in Patients Treated With Bioresorbable and Metallic Stents at 1 Year (BVS-Flow)

Stable Angina

Spain
Liv Hospital Ankara

Completed

Long Term Outcomes Of Hybrid Percutaneous Approach

Coronary Artery Disease
Yonsei University

Unknown

A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold Versus Everolimus-eluting Metallic Stent in Long Coronary Lesions

Coronary Artery Disease

Korea, Republic of
KCRI
SIS Medical AG

Completed

Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds (OPreNBiS)

Coronary Artery Disease | Angina, Stable | Angina, Unstable

Switzerland
SIS Medical AG

Suspended

Absorb BVS vs. Drug Coated Balloon for Treatment Of ISR (AbsorbISR)

Coronary Artery Disease | Coronary Restenosis

Switzerland
Abbott Medical Devices

Completed

ABSORB EXTEND Clinical Investigation (ABSORB EXTEND)

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Cardiovascular Disease | Coronary Restenosis | Coronary Artery Stenosis

Netherlands, Taiwan, China, New Zealand, Singapore, France, United Kingdom, Austria, Israel, Italy, Malaysia, India, Poland, Sweden, Spain, South Africa, Canada, Australia, Japan, Argentina, Brazil, Switzerland, Belgium, Denmark, Germany
J.J. Wykrzykowska
Abbott Medical Devices

Unknown

Bifurcation ABSORB OCT Trial (BISORB OCT)

Myocardial Infarction | Infarction | Ischemia | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease | Arteriosclerosis | Coronary Bifurcation Lesions | Arterial Occlusive Lesions

Netherlands
Seung-Jung Park
CardioVascular Research Foundation, Korea

Terminated

Quantitative Coronary Angiography Versus Imaging GUIDancE for Bioresorbable Vascular Scaffold Implantation (GUIDE-BVS)

Percutaneous Transluminal Coronary Angioplasty

Korea, Republic of
Duk-Woo Park, MD
CardioVascular Research Foundation, Korea

Terminated

Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease (ABSORB-LONG)

Percutaneous Transluminal Coronary Angioplasty

Korea, Republic of
SIS Medical AG

Unknown

Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds (OPreNBiS)

Coronary Artery Disease | Stable Angina | Unstable Angina | Angina

Switzerland
University Hospital Inselspital, Berne

Completed

Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis (INVEST)

Drug-Eluting Stents | Coronary Thrombosis | Tomography, Optical Coherence

Austria, Belgium, France, Germany, Hong Kong, Italy, Netherlands, Singapore, Spain, Switzerland
Ottawa Heart Institute Research Corporation

Withdrawn

Comparative Response to Vascular Injury in Patients With Diabetes Mellitus: An OCT Study of BVS Versus Xience DES

Coronary Artery Disease | Diabetes Mellitus
Spanish Society of Cardiology
Abbott Medical Devices; Fundación de Investigación Biomédica - Hospital Universitario... and other collaborators

Unknown

Restenosis Intrastent: Treatment of Bioresorbable Vascular Scaffolds Restenosis (RIBS VII)

Coronary In-stnent Restenosis

Spain
Biotronik AG
CBCC-VIBGYOR Research Pvt. Ltd.

Suspended

Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold (BIOSOLVE-India)

Coronary Artery Disease

India
Haukeland University Hospital
Oslo University Hospital; Aarhus University Hospital Skejby; University Hospital... and other collaborators

Unknown

Performance of Bioresorbable Scaffold in Primary Percutaneous Intervention of ST Elevation Myocardial Infarct (BVS in STEMI)

Acute ST Segment Elevation Myocardial Infarction

Norway, Denmark
University of Malaya
Boston Scientific Corporation; Kurume University

Completed

ENdothelial Healing Assessment With Novel Coronary tEchnology (ENHANCE)

Coronary Artery Disease
St. Francis Hospital, New York
Akiko Maehara, MD

Unknown

OCT and Scaffold Embedding After NC Balloon

Coronary Artery Disease

United States
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

NeoVas Bioresorbable Coronary Scaffold Registry Study

Coronary Artery Disease

China
Samsung Medical Center

Unknown

REal World Advanced Experience of BioResorbable ScaffolD by SMart Angioplasty Research Team (SMART REWARD)

Acute Coronary Syndromes

Korea, Republic of
Spanish Society of Cardiology
Abbott Medical Devices; Terumo Medical Corporation; Fundación de Investigación... and other collaborators

Unknown

Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring Balloon Pre-dilatation (RIBS VI Scoring)

Coronary In-stent Restenosis

Spain
Spanish Society of Cardiology
Abbott Medical Devices; Terumo Medical Corporation; Fundación de Investigación... and other collaborators

Unknown

Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) (RIBS VI)

Coronary In-stent Restenosis

Spain
Azienda Ospedaliera Bolognini di Seriate Bergamo

Unknown

Use of BVS in ST-segment Elevation Myocardial Infarction (STEMI): the BVS STEMI STRATEGY-IT Prospective Registry (STRATEGY-IT)

ST-elevation Myocardial Infarction (STEMI)

Italy
Medical Care Center Prof. Mathey, Prof. Schofer...
Abbott Medical Devices

Completed

ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (ASSURE)

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases | Coronary Stenosis | Coronary Restenosis

Germany
Lepu Medical Technology (Beijing) Co., Ltd.

Unknown

NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial

Coronary Artery Disease

China

Search clinical trials for: Coronary scaffold

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations